65 results on '"Czene K."'
Search Results
2. 133P Using breast cancer risk factors of women to estimate incidence of breast cancer in their sisters
3. 64P Concomitant discontinuation of cardiovascular therapy and adjuvant hormone therapy in breast cancer patients
4. CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial
5. 135P Hot flashes during adjuvant hormone therapy predict treatment discontinuation and outcome among breast cancer patients
6. Technological readiness and implementation of genomic‐driven precision medicine for complex diseases
7. 75P Use of low-dose tamoxifen to improve mammographic screening sensitivity in premenopausal women
8. 74P Identification of women at high risk of breast cancer who need supplemental screening
9. Determinants of mammographic density change
10. Mammographic density change and risk of breast cancer
11. Disease trajectories and mortality among women diagnosed with breast cancer
12. Abstract PD4-06: A clinical model for assessing the individual breast cancer risk in mammography screening
13. Abstract P6-08-20: Non-adherers of mammography screening: Delayed surgery, early discontinuation of adjuvant hormone therapy, and worse breast cancer outcomes
14. Abstract P4-06-13: BRCA1/2 mutations identified by screening a large unselected breast cancer cohort in Sweden
15. Abstract P3-09-03: Not presented
16. Abstract P6-12-24: Risk and predictors of psoriasis in breast cancer patients: A Swedish population based cohort study
17. Abstract P4-06-15: Targeted sequencing of BRCA1/2 across a large unselected breast cancer cohort in Sweden
18. Increased long-term risk of fatal breast cancer in patients with high intra-tumor heterogeneity of the estrogen receptor – Retrospective analyses of the STO-3 trial
19. Abstract P1-07-07: Gene expression signatures and immunohistochemical subtypes add prognostic value to each other
20. Abstract P2-05-03: Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival – Retrospective analyses of the STO-3 randomized trial
21. Abstract P2-06-06: A clinical model for assessment of the individual breast cancer risk
22. Abstract OT3-06-01: KARISMA, The karma intervention study. - A tamoxifen dose determination trial
23. Abstract P2-03-03: Molecular differences between screen-detected and interval breast cancers are largely explained by PAM50 subtypes
24. Abstract P2-07-03: Insulin and breast cancer risk: Novel insights from mammographic density analyses
25. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
26. Abstract P1-07-22: Infectious disease hospitalization in breast cancer patients: Risk and impact on prognosis
27. 1112 Associations of breast cancer risk prediction tools with tumor characteristics and metastasis: Analysis of polygenic risk score, mammographic density and Tyrer-Cuzick predicted 10-year breast cancer risk
28. 1812 Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival. Retrospective analyses of the STO3 randomizedtrial
29. Background risk of breast cancer influences the association between alcohol consumption and mammographic density
30. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
31. Volumetric Mammographic Density: Heritability and Association With Breast Cancer Susceptibility Loci
32. Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer
33. Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk
34. Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics
35. Abstract P6-06-17: Gene signature model predicts metastatic onset better than standard clinical markers - Nested case-control design uniquely enables enrichment for biologically relevant features
36. Low-dose aspirin use and cancer characteristics: a population-based cohort study
37. Abstract P3-07-03: The impact of Carcinomain situof the breast and family history on risk of subsequent breast cancer events and mortality - a population based study from Sweden
38. Abstract P2-11-06: Mortality among offspring of women diagnosed with breast cancer; a population based study
39. Mammographic density and molecular subtypes of breast cancer
40. High risks of familial chronic lymphatic leukemia for specific relatives: signposts for genetic discovery?
41. AOS9 Mortality in children of women diagnosed with cancer: A population based cohort study
42. AOSOP5 Birth rates among male cancer survivors: A population-based cohort study
43. 131 Mammographic Density, Tumor Characteristics, and Prognosis
44. 319 Clinical Dilemmas in Bilateral Breast Cancer
45. 5188 POSTER Population Survey on Swedish Women's Attitudes Towards Tailored Mammography Screening Based on Individual Risk for Breast Cancer
46. 5182 POSTER Prognosis of Breast Cancer Patients – Causes of Death, Effect of Time Since Diagnosis, Age and Tumour Characteristics
47. P150 Coffee consumption modifies risk of estrogen-receptor negative breast cancer
48. Abstract P4-09-06: Breast Cancer Prognosis Is Inherited Independently of Patient, Tumor and Treatment Characteristics
49. Abstract P3-11-08: Incidence and Outcome of Male and Female Breast Cancer: A Multinational Population Based Study
50. Are Chronic Myeloid Leukemia Patients More at Risk for Second Malignancies? A Population-based Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.